Ex, thanks for sharing your medical opinion, but based on your history of fabricating data I'll choose not to give any credence to your medical opinions.
FYI - even if this trial was all grade 3 brain tumors the 120 month (10 years) survival of 50% of patients is landmark data. Grade 3 mOS is less than 2 years and in this poly-iclc/DCVax-L trial we see 10 years for 50% of the patients.
Grade 3:
^^ Another idiotic take by our IT guru, Ex. Keep spinning Ex.
Regardless,if A+B is better that A that shows something good for B. By itself shows nothing about A.
What's your point, that the science community would prefer playing hind and go seek? Oh I see, let's pretend B doesn't exist, this way, we can say something exclusively about A in the absence of B, which is somewhere hiding in plain sight.